These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19853423)
41. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release. Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704 [TBL] [Abstract][Full Text] [Related]
42. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. Song B; Wu C; Chang J Acta Biomater; 2012 May; 8(5):1901-7. PubMed ID: 22326789 [TBL] [Abstract][Full Text] [Related]
43. Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables. Meeus J; Scurr DJ; Appeltans B; Amssoms K; Annaert P; Davies MC; Roberts CJ; Van den Mooter G Eur J Pharm Biopharm; 2015 Feb; 90():22-9. PubMed ID: 25448071 [TBL] [Abstract][Full Text] [Related]
44. Monodisperse polymeric particles prepared by ink-jet printing: double emulsions, hydrogels and polymer mixtures. Böhmer MR; Steenbakkers JA; Chlon C Colloids Surf B Biointerfaces; 2010 Aug; 79(1):47-52. PubMed ID: 20413282 [TBL] [Abstract][Full Text] [Related]
45. Solvent mediated microstructures and release behavior of insulin from pH-sensitive nanoparticles. Wu ZM; Guo XD; Zhang LJ; Jiang W; Ling L; Qian Y; Chen Y Colloids Surf B Biointerfaces; 2012 Jun; 94():206-12. PubMed ID: 22356870 [TBL] [Abstract][Full Text] [Related]
46. Biodegradable fibre scaffolds incorporating water-soluble drugs and proteins. Ma J; Meng J; Simonet M; Stingelin N; Peijs T; Sukhorukov GB J Mater Sci Mater Med; 2015 Jul; 26(7):205. PubMed ID: 26155976 [TBL] [Abstract][Full Text] [Related]
47. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Lamprecht A; Ubrich N; Hombreiro Pérez M; Lehr C; Hoffman M; Maincent P Int J Pharm; 2000 Mar; 196(2):177-82. PubMed ID: 10699713 [TBL] [Abstract][Full Text] [Related]
48. [Importance of particle size decrease in the preformulation]. Szunyogh T; Ambrus R; Szabóné RP Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303 [TBL] [Abstract][Full Text] [Related]
49. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Dunne M; Corrigan I; Ramtoola Z Biomaterials; 2000 Aug; 21(16):1659-68. PubMed ID: 10905407 [TBL] [Abstract][Full Text] [Related]
50. Drug encapsulation using supercritical fluid extraction of emulsions. Chattopadhyay P; Huff R; Shekunov BY J Pharm Sci; 2006 Mar; 95(3):667-79. PubMed ID: 16447174 [TBL] [Abstract][Full Text] [Related]
51. Formulation Strategy for the Delivery of Cyclosporine A: Comparison of Two Polymeric Nanospheres. Goyal R; Macri L; Kohn J Sci Rep; 2015 Aug; 5():13065. PubMed ID: 26268451 [TBL] [Abstract][Full Text] [Related]
52. A Flow Imaging Microscopy-Based Method Using Mass-to-Volume Ratio to Derive the Porosity of PLGA Microparticles. Sediq AS; Waasdorp SKD; Nejadnik MR; van Beers MMC; Meulenaar J; Verrijk R; Jiskoot W J Pharm Sci; 2017 Nov; 106(11):3378-3384. PubMed ID: 28755925 [TBL] [Abstract][Full Text] [Related]
53. Thermodynamic phase behaviour of indomethacin/PLGA formulations. Prudic A; Lesniak AK; Ji Y; Sadowski G Eur J Pharm Biopharm; 2015 Jun; 93():88-94. PubMed ID: 25791211 [TBL] [Abstract][Full Text] [Related]
54. Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics. Bohr A; Wan F; Kristensen J; Dyas M; Stride E; Baldursdottír S; Edirisinghe M; Yang M J Mater Sci Mater Med; 2015 Feb; 26(2):61. PubMed ID: 25631263 [TBL] [Abstract][Full Text] [Related]
55. Multidrug encapsulation by coaxial tri-capillary electrospray. Lee YH; Bai MY; Chen DR Colloids Surf B Biointerfaces; 2011 Jan; 82(1):104-10. PubMed ID: 20846834 [TBL] [Abstract][Full Text] [Related]
56. PLGA erosion: solubility- or diffusion-controlled? Körber M Pharm Res; 2010 Nov; 27(11):2414-20. PubMed ID: 20721605 [TBL] [Abstract][Full Text] [Related]
57. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect. Sugano K Int J Pharm; 2010 Mar; 387(1-2):103-9. PubMed ID: 20006692 [TBL] [Abstract][Full Text] [Related]
58. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. Philip A; Pathak K PDA J Pharm Sci Technol; 2007; 61(1):24-36. PubMed ID: 17390701 [TBL] [Abstract][Full Text] [Related]
59. Preparation conditions effect on the morphology and release kinetics of biodegradable particles: a mathematical approach. Deloge A; Kalaji N; Sheibat-Othman N; Lin VS; Farge P; Fessi H J Nanosci Nanotechnol; 2009 Jan; 9(1):467-74. PubMed ID: 19441336 [TBL] [Abstract][Full Text] [Related]
60. Investigating the particle to fibre transition threshold during electrohydrodynamic atomization of a polymer solution. Husain O; Lau W; Edirisinghe M; Parhizkar M Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():240-50. PubMed ID: 27157749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]